The 2022 Medicare Physician Fee Schedule rule, the mysterious illness of a man whose urine turned "the color of Coca-Cola," and more.

Moderna tests its first seasonal flu vaccine (Monday, July 12)

Moderna earlier this month announced it began testing its first seasonal flu vaccine, which uses the same mRNA technology the company used to develop its Covid-19 vaccine. According to Moderna CEO Stéphane Bancel, the trial is part of a larger effort to develop a combination vaccine that would target "the most problematic respiratory viruses."

The 50 most influential clinical executives of 2021, according to Modern Healthcare (Tuesday, July 13)

Modern Healthcare recently released its annual list of the "50 Most Influential Clinical Executives," highlighting clinical leaders who continued to innovate "in the face of unprecedented public health, societal, and financial challenges."

Our take: The 2022 Medicare Physician Fee Schedule proposal (Wednesday, July 14)

CMS last week released its proposed rule to update the Medicare Physician Fee Schedule for calendar year 2022, which, among other things, would boost payments for some physicians, reduce payments for others, expand the list of telehealth services that Medicare covers, and make big changes to the Quality Payment Program. Here's what you need to know.

He thought he had the flu. Then, his urine turned 'the color of Coca-Cola.' (Thursday, July 15)

A 22-year-old man initially chalked up his fever and weakness to the flu—until, too weak to get out of bed, he called an ambulance. It was not until he was hospitalized with failing kidneys and "off the charts" blood test results before doctors discovered the real cause of his symptoms, Lisa Sanders reports for the New York Times Magazine.

Covid-19 roundup: What the delta variant does to your body (Friday, July 16)

A new study finds that early infections with the delta variant carry 1,000 times the viral load of infections from previous versions of the coronavirus; what new lab research reveals about vaccines' effectiveness against the delta variant; and more in last week's roundup of Covid-19 news.